The Covid-19 second wave has stretched out overstressed medical professionals and an overburdened healthcare system. And as if these challenges were not enough, we have escalating incidents of frauds including counterfeiting, tampering and diversion of life-saving medicines and other critical essentials such as testing kits, masks etc creating new hurdles and challenges. The ray of hope- vaccines, itself remains vulnerable to the scourge of counterfeiting.
With an increased threat to human lives, ASPA & MFI believe that it is of paramount importance to address the current counterfeit challenges by taking preventive measures, sharing responsibilities / accountabilities amongst all stakeholders towards “Protecting lives & securing the pharmaceutical supply chain during Covid-19”.
This webinar features a Panel Discussion among eminent experts comprising of senior leaders, regulatory officials, and international experts as they come together to analyse issues, discuss practical strategies & collective steps towards combating the counterfeiting menace as well as Covid-19 pandemic.